[Home ] [Archive]    
:: Home :: About Journal :: Registration :: Article Submission :: Contact us :: Site Map ::
:: Volume 14, Issue 1 (March 2022 2022) ::
IJBC 2022, 14(1): 6-11 Back to browse issues page
Mir 143 rs353293 G>A Polymorphism is Not Associated with the Risk of Thyroid Cancer in the Iranian Population: A Case-Control Study
Nima Montazeri-Najafabady, Mohammad Hossein Dabbaghmanesh *, Nazanin Chatrabnous, Mohammad Reza Arabnezhad, Rajeeh Mohammadian Amiri
Shiraz Endocrine and Metabolism Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract:   (154 Views)
Background: Single nucleotide polymorphisms (SNPs) in the promoter region of miRNAs may disturb miRNAs processing, alter their expression, and ultimately affect an individual’s susceptibility to cancer. We conducted a case-control study to evaluate the association of rs353293 G>A with the risk of thyroid cancer in the Iranian population.
Methods: 192 patients with thyroid cancer including (papillary, follicular, medullary, and undifferentiated) and 125 healthy subjects were enrolled in this case-control study. rs353293 G>A polymorphism in the promoter region of miR-143/145 were analyzed using polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) to find the association of this SNP with thyroid cancer. Logistic regression analyses were conducted to evaluate adjusted odds ratios (ORs) for the potential confounding factors (age and sex), and 95% confidence intervals (95% CIs) between patients with thyroid cancer and controls.
Results: We found no association between rs353293 G>A polymorphism and thyroid cancer. 
Conclusion: This study suggests that the functional polymorphism in rs353293 is not associated with development of thyroid cancer. Future investigations with larger sample size should be performed to confirm our observations.
Keywords: Thyroid cancer, rs353293 G>A polymorphism, Mir 143, RFLP
Full-Text [PDF 455 kb]   (31 Downloads)    
: Research | Subject: Genetics
Received: 2020/06/16 | Accepted: 2022/03/8 | Published: 2022/04/30
* Corresponding Author Address: Shiraz Endocrine and Metabolism Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Montazeri-Najafabady N, Dabbaghmanesh M H, Chatrabnous N, Arabnezhad M R, Mohammadian Amiri R. Mir 143 rs353293 G>A Polymorphism is Not Associated with the Risk of Thyroid Cancer in the Iranian Population: A Case-Control Study. IJBC. 2022; 14 (1) :6-11
URL: http://ijbc.ir/article-1-1022-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 14, Issue 1 (March 2022 2022) Back to browse issues page
مجله ی خون و سرطان ایران Iranian Journal of Blood and Cancer
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4410